How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/induction-of-ovulation-in-polycystic-ovarian-syndrome.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Induction of ovulation in polycystic ovarian syndrome — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Induction of ovulation in polycystic ovarian syndrome (disease) competitive landscape: 4 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

4 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Induction of ovulation in polycystic ovarian syndrome, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Femara	letrozole	Novartis AG	Aromatase Inhibitor [EPC]	aromatase enzyme	1997-07-25
Glucophage	metformin	Generic (originally Merck Serono/Lipha)	Dipeptidyl Peptidase 4 Inhibitor [EPC]	5'-AMP-activated protein kinase subunit beta-1, Solute carrier family 22 member 1, Solute carrier family 22 member 2	1995-03-03
Glucophage	Glucophage	Dr. Reddy's Laboratories Limited		5'-AMP-activated protein kinase subunit beta-1, Solute carrier family 22 member 1, Solute carrier family 22 member 2
Femara	Femara	M.D. Anderson Cancer Center		Cytochrome P450 11B2, mitochondrial, Aromatase, Cytochrome P450 11B1, mitochondrial

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Dr. Reddy's Laboratories Limited · 1 drug in Induction of ovulation in polycystic ovarian syndrome
Generic (originally Merck Serono/Lipha) · 1 drug in Induction of ovulation in polycystic ovarian syndrome
M.D. Anderson Cancer Center · 1 drug in Induction of ovulation in polycystic ovarian syndrome
Novartis AG · 1 drug in Induction of ovulation in polycystic ovarian syndrome

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Induction of ovulation in polycystic ovarian syndrome:

Cite this brief

Drug Landscape (2026). Induction of ovulation in polycystic ovarian syndrome — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/induction-of-ovulation-in-polycystic-ovarian-syndrome. Accessed 2026-06-10.

Induction of ovulation in polycystic ovarian syndrome full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing